Literature DB >> 34890263

2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report.

David D Gummin1, James B Mowry2, Michael C Beuhler3, Daniel A Spyker4, Alvin C Bronstein5, Laura J Rivers6, Nathaniel P T Pham7, Julie Weber8.   

Abstract

INTRODUCTION: This is the 38th Annual Report of the American Association of Poison Control Centers' (AAPCC) National Poison Data System (NPDS). As of 1 January, 2020, all 55 of the nation's poison centers (PCs) uploaded case data automatically to NPDS. The upload interval was 6.15 [4.60, 8.62] (median [25%, 75%]) minutes, effectuating a near real-time national exposure and information database and surveillance system.
METHODS: We analyzed the case data tabulating specific indices from NPDS. The methodology was similar to that of previous years. Where changes were introduced, the differences are identified. Cases with medical outcomes of death were evaluated by a team of medical and clinical toxicologist reviewers using an ordinal scale of 1-6 to assess the Relative Contribution to Fatality (RCF) of the exposure.
RESULTS: In 2020, 3,316,738 closed encounters were logged by NPDS: 2,128,198 human exposures, 66,745 animal exposures, 1,116,568 information requests, and 5,160 human confirmed nonexposures. Total encounters showed a 28.9% increase from 2019, while health care facility (HCF) human exposure cases decreased by 10.6%. While all information requests increased by 218.0%, medication identification (Drug ID) requests decreased by 31.5%, and human exposure cases decreased by 0.928%. Medical Information requests showed a 32.6-fold increase, reflecting COVID-19 pandemic calls to PCs. Human exposures with less serious outcomes have decreased 1.90% per year since 2008, while those with more serious outcomes (moderate, major or death) have increased 4.59% per year since 2000.Consistent with the previous year, the top 5 substance classes most frequently involved in all human exposures were analgesics (10.3%), household cleaning substances (8.37%), cosmetics/personal care products (6.53%), antidepressants (5.30%), and sedatives/hypnotics/antipsychotics (4.92%). As a class, antidepressant exposures increased most rapidly, by 1,793 cases/year (5.84%/year) over the past 10 years for cases with more serious outcomes.The top 5 most common exposures in children age 5 years or less were cosmetics/personal care products (11.8%), household cleaning substances (11.3%), analgesics (7.57%), foreign bodies/toys/miscellaneous (6.71%), and dietary supplements/herbals/homeopathic (6.44%). Drug identification requests comprised 2.89% of all information contacts. NPDS documented 4,488 human exposures resulting in death; 3,869 (86.2%) of these were judged as related (RCF of 1-Undoubtedly responsible, 2-Probably responsible, or 3-Contributory).
CONCLUSIONS: These data support the continued value of PC expertise and need for specialized medical toxicology information to manage more serious exposures. Unintentional and intentional exposures continue to be a significant cause of morbidity and mortality in the US. The near real-time status of NPDS represents a national public health resource to collect and monitor US exposure cases and information contacts. The continuing mission of NPDS is to provide a nationwide infrastructure for surveillance for all types of exposures (e.g., foreign body, infectious, venomous, chemical agent, or commercial product), and the identification and tracking of significant public health events. NPDS is a model system for the near real-time surveillance of national and global public health.

Entities:  

Year:  2021        PMID: 34890263     DOI: 10.1080/15563650.2021.1989785

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  7 in total

1.  Determination of Patient Adherence for Duloxetine in Urine.

Authors:  Haley A Mulder; Greg L McIntire; Frank N Wallace; Justin L Poklis
Journal:  J Anal Toxicol       Date:  2022-10-14       Impact factor: 3.220

2.  Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021.

Authors:  Joseph J Palamar; Linda B Cottler; Bruce A Goldberger; Stevan Geoffrey Severtson; David J Grundy; Janetta L Iwanicki; Daniel Ciccarone
Journal:  Am J Drug Alcohol Abuse       Date:  2022-06-15       Impact factor: 3.912

3.  Carbamazepine Overdose after Psychiatric Conditions: A Case Study for Postmortem Analysis in Human Bone.

Authors:  Lucia Fernández-López; Rosanna Mancini; Maria-Concetta Rotolo; Javier Navarro-Zaragoza; Juan-Pedro Hernández Del Rincón; Maria Falcón
Journal:  Toxics       Date:  2022-06-13

4.  Pediatric Melatonin Ingestions - United States, 2012-2021.

Authors:  Karima Lelak; Varun Vohra; Mark I Neuman; Michael S Toce; Usha Sethuraman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-06-03       Impact factor: 35.301

Review 5.  Calcium Channel Blocker Toxicity: A Practical Approach.

Authors:  Omar A Alshaya; Arwa Alhamed; Sara Althewaibi; Lolwa Fetyani; Shaden Alshehri; Fai Alnashmi; Shmeylan Alharbi; Mohammed Alrashed; Saleh F Alqifari; Abdulrahman I Alshaya
Journal:  J Multidiscip Healthc       Date:  2022-08-30

Review 6.  The application of genome-wide CRISPR-Cas9 screens to dissect the molecular mechanisms of toxins.

Authors:  Bei Wang; Jun-Zhu Chen; Xue-Qun Luo; Guo-Hui Wan; Yan-Lai Tang; Qiao-Ping Wang
Journal:  Comput Struct Biotechnol J       Date:  2022-09-13       Impact factor: 6.155

Review 7.  Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements.

Authors:  Deanna M Minich; Melanie Henning; Catherine Darley; Mona Fahoum; Corey B Schuler; James Frame
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.